Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review

Hdl Handle:
http://hdl.handle.net/10144/619092
Title:
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review
Authors:
Atwine, D; Bonnet, M; Taburet, AM
Journal:
British Journal of Clinical Pharmacology
Abstract:
Efavirenz (EFV) and Rifampicin-Isoniazid (RH) are cornerstone drugs in HIV-tuberculosis (TB) co-infection treatment but with complex drug interactions, efficacy and safety challenges. We reviewed recent data on EFV and RH interaction in TB/HIV high-burden countries.
Publisher:
Wiley-Blackwell
Issue Date:
6-Apr-2018
URI:
http://hdl.handle.net/10144/619092
DOI:
10.1111/bcp.13600
PubMed ID:
29624706
Submitted date:
2018-04-17
Language:
en
ISSN:
1365-2125
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorAtwine, Den
dc.contributor.authorBonnet, Men
dc.contributor.authorTaburet, AMen
dc.date.accessioned2018-04-17T16:34:49Z-
dc.date.available2018-04-17T16:34:49Z-
dc.date.issued2018-04-06-
dc.date.submitted2018-04-17-
dc.identifier.citationPharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review. 2018 Br J Clin Pharmacolen
dc.identifier.issn1365-2125-
dc.identifier.pmid29624706-
dc.identifier.doi10.1111/bcp.13600-
dc.identifier.urihttp://hdl.handle.net/10144/619092-
dc.description.abstractEfavirenz (EFV) and Rifampicin-Isoniazid (RH) are cornerstone drugs in HIV-tuberculosis (TB) co-infection treatment but with complex drug interactions, efficacy and safety challenges. We reviewed recent data on EFV and RH interaction in TB/HIV high-burden countries.en
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.rightsArchived with thanks to British Journal of Clinical Pharmacologyen
dc.titlePharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic reviewen
dc.identifier.journalBritish Journal of Clinical Pharmacologyen
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.